Children who receive growth hormone to treat short stature or hormone deficiency may be at an increased risk of ischemic stroke as young adults, suggests a new European study.
The FDA approved a once-daily, long-term olodaterol inhalation spray to treat patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema with airflow obstruction.